(R)-Metomidate
|
依托咪酯杂质
|
61045-91-8
|
Etomidate EP Impurity A
|
依托咪酯杂质A
|
3157-27-5
|
LRE1
|
化合物 T15787
|
1252362-53-0
|
TUG-469
|
TUG-469
|
1236109-67-3
|
Benzenepropanoicacid
|
3,5-二(叔丁基)-4-羟基-苯丙酸,3-羟基-2,2-双(羟甲基)丙酯
|
26347-98-8
|
MMRi62
|
7-((2,3-二氯苯基)(吡啶-2-基氨基)甲基)喹啉-8-醇
|
352693-80-2
|
C3a receptor agonist 1
|
2-环己基-2-苯基-N-[1-(3-吡啶-3-基丙酰基)哌啶-4-基]乙酰胺
|
944997-60-8
|
CP-289503
|
化合物CP-289
|
1349637-14-4
|
Todralazine hydrochloride
|
盐酸托屈嗪
|
3778-76-5
|
hMAO-B-IN-4
|
|
1666119-75-0
|
HIF-1 inhibitor-4
|
WAY-299838
|
333357-56-5
|
p38α inhibitor 3
|
WAY-313218
|
260428-69-1
|
DC-TEADin02
|
化合物DC-TEADIN02
|
2380228-45-3
|
Nampt activator-1
|
|
701929-65-9
|
(Rac)-Brassinazole
|
3-(4-氯苯基)-1-甲基-1-苯基-2-(1,2,4-三唑-1-基)-1-丙醇
|
224047-41-0
|
ALW-II-49-7
|
|
1135219-23-6
|
ROCK-IN-5
|
2-(2-氯-6-氟苯基)-N-(4-(吡啶-4-基)噻唑-2-基)乙酰胺
|
692870-25-0
|
LP-471756
|
化合物 T27850
|
413605-11-5
|
NLRP3-IN-10
|
化合物 NLRP3-IN-10
|
2641826-39-1
|
CP-447697
|
4-[(苯并[B]噻吩-3-基羰基)[2-(4-氯苯基)乙基]氨基]-N-(2,4-二氟苯基)-1-哌啶甲酰胺
|
1092847-21-6
|
BRD4 Inhibitor-20
|
化合物 BRD4 INHIBITOR-20
|
2490311-14-1
|
MPT0B014
|
B014
|
1215208-59-5
|
HCV-IN-31
|
Adenosine, 2-amino-2'-deoxy-2'-fluoro-N,2'-dimethyl-, (2'R)-
|
1998705-62-6
|
SG-094
|
SG094
|
2922283-37-0
|
UPGL00004
|
UPGL00004
|
1890169-95-5
|
TH34
|
CS-2858
|
2196203-96-8
|
RG 14620
|
TYRPHOSTIN RG 14620
|
136831-49-7
|
BYK 191023 dihydrochloride
|
BYK191023二盐酸盐
|
1216722-25-6
|
Imiquimod Impurity
|
咪喹莫特杂质
|
99010-41-0
|
Olaparib Impurity
|
奥拉帕尼杂质
|
2415448-60-9
|
Buspirone Impurity
|
丁螺环酮杂质
|
2726492-72-2
|
Letermovir Impurity
|
1,3-双(2-甲氧基-5-(三氟甲基)苯基)脲
|
6064-14-8
|
2(1H)-Pyridinone,4-hydroxy-5-methyl-(9CI)
|
非奈利酮杂质
|
41935-71-1
|
THAL-SNS-032
|
THAL-SNS-032
|
2139287-33-3
|
Gsk484 hydrochloride
|
CS-2265
|
1652591-81-5
|
ARV-766
|
4-(4-((1-(4-((反式-3-(4-氰基-3-甲氧基苯氧基)-2,2,4,4-四甲基环丁基)氨基甲Chemicalbook酰基)苯基)哌啶-4-基)甲基)哌嗪-1-基)-N-((S)-2,6-二氧代嘧啶-3-基)-2-氟苯甲酰胺
|
2750830-09-0
|
GSK215
|
GSK215
|
2743427-26-9
|
BI-2865
|
(4S)-2-氨基-4,5,6,7-四氢-4-甲基-4-[3-[4-[(1S)-1-[(2S)-1-甲基-2-吡咯烷基]乙氧基]-2-嘧啶基]-1,2,4-恶二唑-5-基]苯并[b]噻吩-3-甲腈
|
2937327-93-8
|
TH-Z93
|
|
2260887-09-8
|
2-(2,6-dichloro-3,5-dimethoxyphenyl)acetonitrile
|
2-(2,6-二氯-3,5-二甲氧基苯基)乙腈
|
869882-16-6
|
VH032
|
VH-032
|
1448188-62-2
|
TD-106
|
TD-106
|
2250288-69-6
|
RN-18
|
431980-38-0
|
431980-38-0
|
Laninamivir
|
拉尼米韦
|
203120-17-6
|
917389-35-6
|
来特莫韦杂质
|
917389-35-6
|
LeterMovir-008-R
|
莱特莫韦杂质
|
917389-34-5
|
LeterMovir-013
|
莱特莫韦杂质
|
917389-37-8
|
2-Propenoic acid, 3-[3-fluoro-2-[[[4-(3-methoxyphenyl)-1-piperazinyl][[2-methoxy-5-(trifluoromethyl)phenyl]imino]methyl]amino]phenyl]-, methyl ester, (2E)-
|
莱特莫韦杂质
|
1791412-04-8
|
dTRIM24
|
dTRIM24
|
2170695-14-2
|
ASTX660
|
ASTX660
|
1799328-86-1
|
DBRD9
|
DBRD9
|
2170679-45-3
|
CA-4948
|
CA-4948
|
1801343-74-7
|
BMS-P5
|
BMS-P5
|
1550371-22-6
|
VB-124
|
VB-124
|
2230186-18-0
|
Letermovir Impurity
|
917389-29-8
|
917389-29-8
|
SCH529074
|
SCH 529074
|
922150-11-6
|
RBM013209
|
RBN013209
|
2597933-17-8
|
SLX-4090
|
913541-47-6
|
913541-47-6
|
(S)-Remoxipride Hydrochloride
|
瑞莫必利盐酸盐
|
73220-03-8
|
BOS318
|
化合物BOS-318
|
2387633-15-8
|
CNX-1351
|
CNX1351
|
1276105-89-5
|
GDC-6036
|
GDC6036
|
2417987-45-0
|
NAcM-OPT
|
化合物NACM-OPT
|
2089293-61-6
|
R-10015
|
2-(1-(5-氯-7H-吡咯并[2,3-D]嘧啶-4-基)哌啶-4-基)-1H-苯并[D]咪唑-6-羧酸甲酯
|
2097938-51-5
|
FK-3311
|
N-[4-乙酰基-2-(2,4-二氟苯氧基)苯基]-甲烷磺酰胺
|
116686-15-8
|
SAR407899
|
6-(4-哌啶基氧基)-1(2H)-异喹啉酮
|
923359-38-0
|
C-DIM 12
|
C-DIM12
|
178946-89-9
|
C-215
|
N-[(2,4-dichlorophenyl)methyl]-1-propylbenzimidazol-5-amine
|
912780-51-9
|
AU1235
|
1338780-86-1
|
1338780-86-1
|
NS 398
|
N-[2-(环己氧基)-4-硝基苯基]甲基磺酰胺
|
123653-11-2
|
ASP7663
|
ASP 7663;ASP-7663;ASP7663
|
1190217-35-6
|
BM635
|
BM635
|
1493762-74-5
|
Auten-99 HBr
|
2-([1,1'-联苯]-4-基)-5,6-二氢咪唑并[2,1-b]噻唑氢溴酸盐
|
1049780-58-6
|
INS3-54A18
|
3-(4-氯亚苄基)-1-(4-羟苯基)-5-苯基-1H-吡咯-2(3H)-酮
|
328998-53-4
|
Loreclezole
|
(Z)-1-(2-氯-2-(2,4-二氯苯基)乙烯基)-1H-1,2,4-三唑
|
117857-45-1
|
Eprotirome
|
3-((3,5-二溴-4-(4-羟基-3-异丙基苯氧基)苯基)氨基)-3-氧代丙酸
|
355129-15-6
|
EB-3D
|
1,1'-(((乙烷-1,2-二基双(氧基))双(4,1-亚苯基))双(亚甲基))双(4-(二甲氨基)吡啶-1-鎓)溴化物
|
1839150-63-8
|
ML402
|
298684-44-3
|
298684-44-3
|
A 438079 hydrochloride
|
3-[[5-(2,3-二氯苯基)-1H-四唑-1-基]甲基]吡啶单盐酸盐
|
899431-18-6
|
CB-7921220
|
6-(4-氨基苯乙烯基)吡啶-2-羧酸
|
115453-99-1
|
KY1220
|
5-((1-(4-硝基苯基)-1H-吡咯-2-基)亚甲基)-2-硫代咪唑烷-4-酮
|
292168-79-7
|
UPF1069
|
5-(2-氧代-2-苯基乙氧基)-1(2H)-异喹啉酮
|
1048371-03-4
|
AF40431
|
AF40431
|
181125-92-8
|
Y06036
|
5-溴-2-甲氧基-N-(6-甲氧基-3-甲基苯并[d]异恶唑-5-基)苯磺酰胺
|
1832671-96-1
|
MJN110
|
2,5-二氧吡咯烷-1-基4-(双(4-氯苯基)甲基)哌嗪-1-羧酸酯
|
1438416-21-7
|
NITD-349
|
N-(4,4-二甲基环己基)-4,6-二氟-1H-吲哚-2-甲酰胺
|
1473450-62-2
|
MSDC-0602
|
5-(4-(2-(3-甲氧基苯基)-2-氧代乙氧基)苄基)噻唑烷-2,4-二酮
|
1133819-87-0
|
BM212
|
1-((1,5-二(4-氯苯基)-2-甲基-1H-吡咯-3-基)甲基)-4-甲基哌嗪
|
146204-42-4
|
CGP-53716
|
N-(4-甲基-3-((4-(吡啶-3-基)嘧啶-2-基)氨基)苯基)苯甲酰胺
|
152459-94-4
|
Nomifensine maleate
|
诺米芬新马来酸盐
|
32795-47-4
|
NE-100 hydrochloride
|
N,N-二乙基-2-(4-甲氧基-3-苯乙基氧基苯基)乙胺盐酸盐
|
149409-57-4
|
Atopaxar Hydrobromide
|
2-(5,6-二乙氧基-7-氟-1,3-二氢-1-亚氨基-2H-异吲哚-2-基)-1-[3-叔丁基-4-甲氧基-5-(4-吗啉基)苯基]乙酮
|
751475-53-3
|
ST034307
|
6-氯-2-(三氯甲基)-4H-苯并吡喃-4-酮
|
133406-29-8
|
4-Quinazolineacetic acid, 8-fluoro-3,4-dihydro-2-[4-(3-methoxyphenyl)-4-oxido-1-piperazinyl]-3-[2-methoxy-5-(trifluoromethyl)phenyl]-, (4S)-
|
来特莫韦杂质
|
2991059-71-1
|
1-(2-(3-formyl-N-methylbenzamido)ethyl)piperidin-4-yl [1,1'-biphenyl]-2-ylcarbamate
|
1-(2-(3-甲酰基-N-甲基苯甲酰氨基)乙基)哌啶-4-基[1,1'-联苯]-2-基氨基甲酸酯
|
864760-28-1
|
PIP-199
|
PIP-199
|
622795-76-0
|
Butanedioic acid, 2,3-bis[(4-methylbenzoyl)oxy]-, (2S,3S)-, compd. with methyl (4S)-8-fluoro-3,4-dihydro-2-[4-(3-methoxyphenyl)-1-piperazinyl]-3-[2-methoxy-5-(trifluoromethyl)phenyl]-4-quinazolineacetate (1:1)
|
莱特莫韦杂质
|
917389-30-1
|
VK-II-36
|
化合物VK-II-43
|
955371-66-1
|
ML67-33
|
ML67-33
|
1443290-89-8
|
Picotamide
|
吡考胺
|
32828-81-2
|
2-Pyrazinecarbonitrile, 6-ethyl-3-[[3-methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]amino]-5-[(tetrahydro-2H-pyran-4-yl)amino]-
|
吉列替尼N-1
|
2043019-99-2
|
GSK3359088
|
GSK 3359088
|
1628830-21-6
|